RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Integra Lifesciences Holdings - Stock

Integra Lifesciences Holdings Market capitalization 2024

Integra Lifesciences Holdings Market capitalization

2.47 B USD

Integra Lifesciences Holdings Dividend yield

Ticker

IART

ISIN

US4579852082

WKN

897013

In 2024, Integra Lifesciences Holdings's market cap stood at 2.47 B USD, a -23.54% increase from the 3.24 B USD market cap in the previous year.

The Integra Lifesciences Holdings Market capitalization history

YEARREVENUE (undefined USD)GROSS MARGIN (%)NET INCOME (undefined USD)
2027e1.9848,99409.11
2026e1.8951,43296.47
2025e1.8153,82266.86
2024e1.7156,91243.96
20231.5463,0967.74
20221.5663,04180.6
20211.5463,34169.1
20201.3764,55133.9
20191.5264,4550.2
20181.4763,5460.8
20171.1965,4664.7
20160.9966,7274.6
20150.8864,98-3.5
20140.864,2034
20130.8460,89-21.1
20120.8364,1441.2
20110.7861,6528
20100.7363,3765.7
20090.6864,1251
20080.6561,3827.7
20070.5561,0025.3
20060.4259,8629.4
20050.2861,5037.2
20040.2361,4917.2

Integra Lifesciences Holdings Aktienanalyse

What does Integra Lifesciences Holdings do?

Integra Lifesciences Holdings Corp is a multinational manufacturer and provider of medical devices, implants, and instruments. The company is headquartered in Plainsboro, New Jersey and was founded in 1989. Integra Lifesciences specializes in the development and marketing of products for orthopedic surgery, neurosurgery, and plastic and reconstructive surgery. The company has a wide range of products that have been constantly improved and expanded over the years. The history of Integra Lifesciences is characterized by continuous expansion through the acquisition of other companies. In 1996, the company acquired Confluent Surgical, which allowed them to enter the tissue adhesive sector. In the following years, several companies were acquired, including Depuy Orthopaedics, Kaye Surgical, and SeaSpine Holdings. Each acquisition has contributed to Integra Lifesciences being able to offer its customers an extensive product portfolio that meets all requirements. Integra Lifesciences has a diversified business model that focuses on four different divisions: anesthesia, neurosurgery, plastic and reconstructive surgery, and orthopedic surgery. Each division has its own range of products that are tailored to the specific requirements of its customers. Integra Lifesciences supplies high-quality medical instruments that are valued by surgeons around the world. These include products such as bone cement, implants, skull plates, bone screws, tissue adhesives, and spinal fusion devices. All products from Integra Lifesciences aim to improve patient care and enhance patients' quality of life. The anesthesia division offers a wide range of products and technologies that improve the administration of anesthesia and enable optimal patient care. In addition to traditional products such as anesthesia masks and tubes, Integra Lifesciences also develops innovative products such as disposable ventilation systems that can increase safety and efficiency. The neurosurgery division offers a wide range of devices and implants for the treatment of brain and spinal cord conditions. The product range includes skull plates, bone connectors, and devices for performing brain surgeries. In the plastic and reconstructive surgery division, Integra Lifesciences offers products for the treatment of burns and the reconstruction of bones and soft tissues. The company has a wide range of products, including skin grafts, scar treatment, and liposuction. Orthopedic surgery is one of the established divisions at Integra Lifesciences, offering a wide range of products for the treatment of bone and joint problems. The company provides implants and instruments for all types of orthopedic procedures, including hip and knee replacements, spinal fusion, and limb reconstruction. Overall, Integra Lifesciences Holdings Corp is a leading manufacturer of medical devices, implants, and instruments specializing in the fields of orthopedics, neurosurgery, and plastic and reconstructive surgery. With its comprehensive product range and innovative technologies, Integra Lifesciences has gained a leading position in the industry, providing its customers worldwide with the highest quality and safety. Integra Lifesciences Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Integra Lifesciences Holdings's Market Capitalization

Integra Lifesciences Holdings's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Integra Lifesciences Holdings's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Integra Lifesciences Holdings's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Integra Lifesciences Holdings’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Integra Lifesciences Holdings Stock

What is the current Integra Lifesciences Holdings market capitalization?

The current market capitalization of Integra Lifesciences Holdings is 2.47 B USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Integra Lifesciences Holdings.

How has the market capitalization of Integra Lifesciences Holdings developed in recent years?

The market capitalization of Integra Lifesciences Holdings has increased/decreased by -23.54% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Integra Lifesciences Holdings?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Integra Lifesciences Holdings?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Integra Lifesciences Holdings have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Integra Lifesciences Holdings pay?

Over the past 12 months, Integra Lifesciences Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Integra Lifesciences Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Integra Lifesciences Holdings?

The current dividend yield of Integra Lifesciences Holdings is .

When does Integra Lifesciences Holdings pay dividends?

Integra Lifesciences Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Integra Lifesciences Holdings?

Integra Lifesciences Holdings paid dividends every year for the past 0 years.

What is the dividend of Integra Lifesciences Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Integra Lifesciences Holdings located?

Integra Lifesciences Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Integra Lifesciences Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Integra Lifesciences Holdings from 6/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/10/2024.

When did Integra Lifesciences Holdings pay the last dividend?

The last dividend was paid out on 6/10/2024.

What was the dividend of Integra Lifesciences Holdings in the year 2023?

In the year 2023, Integra Lifesciences Holdings distributed 0 USD as dividends.

In which currency does Integra Lifesciences Holdings pay out the dividend?

The dividends of Integra Lifesciences Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Integra Lifesciences Holdings

Our stock analysis for Integra Lifesciences Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Integra Lifesciences Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.